fulvestrant has been researched along with Adenocarcinoma in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (16.28) | 18.2507 |
| 2000's | 23 (53.49) | 29.6817 |
| 2010's | 12 (27.91) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Razik, AF; Alexi, X; Alexis, MN; Ioannou, E; Roussis, V; Vagias, C | 1 |
| Ahn, SJ; Cho, JY; Cho, SJ; Kang, S; Kim, SG; Park, M; Yoon, C | 1 |
| Andò, S; Barone, I; Bornert, JM; Catalano, S; Emprou, C; Laverny, G; Malivindi, R; Metzger, D; Panza, S; Rizza, P; Rovito, D | 1 |
| Fan, S; Fu, X; Liao, Y; Liu, C; Wang, J; Xiong, J; Zhou, S; Zou, M | 1 |
| Chen, G; Fu, S; Liao, Y; Liu, Z; Tang, H; Xu, L; Yu, L; Zhang, C; Zhou, S | 1 |
| Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M | 1 |
| Choi, KC; Go, RE; Hwang, KA; In, SJ; Kim, SH | 1 |
| Ashraf, U; Chadha, MK; Escott, P; Lawrence, D; Levine, E; Payne, V; Silliman, C; Tian, L; Trump, DL | 1 |
| Dacic, S; Dubey, S; Eickhoff, JC; Hoang, T; Kolesar, JM; Marcotte, SM; Schiller, JH; Siegfried, JM; Stabile, LP; Traynor, AM | 1 |
| Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
| Cheng, P; Hershberger, PA; Kanterewicz, B; Liu, Y; McCarty, KS; Nichols, M | 1 |
| Dougherty, SM; Ivanova, MM; Klinge, CM; Mazhawidza, W | 1 |
| Amoroso, D; Camerini, A; Donati, S; Garrone, O; Mattiot, VP; Porta, RP; Puccetti, C; Puccinelli, P; Rondini, M; Sgambato, A; Siclari, O; Tartarelli, G; Valsuani, C; Vincenti, M | 1 |
| Conte, P; Frassoldati, A; Guarneri, V | 1 |
| Miles, DW | 1 |
| Arteaga, CL; Balko, JM; Buck, E; Fox, EM; González-Angulo, AM; Kuba, MG; Liu, S; Manning, HC; Miller, TW; Mills, GB; Sánchez, V; Shyr, Y; Smith, RA; Ye, F | 1 |
| Gao, W; Guo, R; Shen, H; Shu, Y; Sun, J; Xu, R | 1 |
| Carlson, KE; Chan, SR; Dence, CS; Fettig, NM; Fowler, AM; Jeyakumar, M; Katzenellenbogen, JA; Schreiber, RD; Sharp, TL; Welch, MJ; Zhou, D | 1 |
| Harada, A; Li, C; Oh, Y | 1 |
| Giese, H; Klitgaard, LG; Kobayashi, H; Purup, S; Sondergaard, TE; Sørensen, JL | 1 |
| Bergman, A; Brouwer, A; Giesy, JP; Lemmen, JG; Letcher, RJ; van den Berg, M; van der Burg, B | 1 |
| Balkenende, A; Bindels, EM; Lallemand, F; Michalides, R; Verwoerd, D | 1 |
| Bogart, DF; Castañeda, JM; Li, P; Lupu, R; Tsai, MS | 1 |
| Banerjee, S; Banerjee, SK; Saxena, N; Sengupta, K | 1 |
| Farnell, YZ; Ing, NH | 1 |
| Chaouat, M; Forgez, P; Gompel, A; Jacob, D; Perrot, JY; Rostène, W; Somaï, S | 1 |
| Hopert, AC; Schubert, C; Strunck, E; Tüshaus, L; Vollmer, G; Wünsche, W | 1 |
| Bjeldanes, LF; Firestone, GL; Leong, H; Riby, JE | 1 |
| Laing, E; Sunder, A; Temple, JL; Wray, S | 1 |
| Guo, RX; Li, XP; Wang, JL; Wei, LH; Zhao, D | 1 |
| Carcel-Trullols, J; Evans, TT; Higuchi, M; Mizumachi, T; Naito, A; Xie, CH | 1 |
| Dive, C; Hickman, JA; Morris, ID; Wakeling, AE; Wilson, JW | 1 |
| Thomas, ML; Xu, X | 1 |
| Crew, AJ; Langdon, SP; Miller, WR; Muir, M; Ritchie, AA; Smyth, JF; Wakeling, A | 1 |
| Jordan, VC; Pink, JJ | 1 |
| Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Merand, Y; Poirier, D; Sanchez, R; Simard, J; Singh, SM | 1 |
| Huper, G; Iglehart, JD; Lobenhofer, EK; Marks, JR | 1 |
| Archer, C; Assersohn, L; Boeddinghaus, I; Chang, J; Dowsett, M; Ellis, PA; Gregory, RK; Johnston, SR; Mainwaring, P; Powles, TJ; Salter, J; Smith, IE | 1 |
| Pento, JT; Rajah, TT | 1 |
| Conrad, SE; Varma, H | 1 |
| Appa Rao, KB; Gui, Y; Lessey, BA; Lovely, LP | 1 |
| Sampath, D; Winneker, RC; Zhang, Z | 1 |
| Bogart, DF; Li, P; Lupu, R; Mehmi, I; Tsai, MS | 1 |
1 review(s) available for fulvestrant and Adenocarcinoma
| Article | Year |
|---|---|
Clinical studies of apoptosis and proliferation in breast cancer.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers; Breast Neoplasms; Cell Division; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pregnancy; Tamoxifen; Tumor Cells, Cultured | 1999 |
2 trial(s) available for fulvestrant and Adenocarcinoma
| Article | Year |
|---|---|
Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Castration; Disease Progression; Dose-Response Relationship, Drug; Estradiol; Fulvestrant; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Middle Aged; Prostatic Neoplasms; Receptors, Estrogen; Treatment Outcome | 2008 |
Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cholesterol; Cholesterol, LDL; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Lipid Metabolism; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Postmenopause; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Triglycerides | 2009 |
40 other study(ies) available for fulvestrant and Adenocarcinoma
| Article | Year |
|---|---|
9,11-Secosterols with antiproliferative activity from the gorgonian Eunicella cavolini.
Topics: Adenocarcinoma; Animals; Anthozoa; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Estrogens; Female; Humans; Male; Molecular Structure; Prostatic Neoplasms; Sterols | 2009 |
Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma.
Topics: Adenocarcinoma; Antigens, Bacterial; Bacterial Proteins; Cytotoxins; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Helicobacter Infections; Helicobacter pylori; Humans; Stomach Neoplasms | 2022 |
Conditional expression of Ki-Ras
Topics: Adenocarcinoma; Animals; Epithelium; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Gene Expression; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Mutation, Missense; Tumor Cells, Cultured | 2017 |
G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
Topics: A549 Cells; Adenocarcinoma; Animals; Benzodioxoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Humans; Lung Neoplasms; Mice; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Urethane | 2019 |
Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents, Hormonal; Carcinogenesis; Disease Models, Animal; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Middle Aged; Signal Transduction; Tissue Array Analysis; Urethane | 2014 |
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays | 2015 |
Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.
Topics: Adenocarcinoma; Benzophenones; Biomarkers; Breast Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Endocrine Disruptors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Proteins; Osmolar Concentration; Phenols; Photosensitizing Agents; RNA, Messenger | 2015 |
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Postmenopause; Prognosis; Quinazolines; Safety; Survival Rate; Treatment Outcome | 2009 |
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Topics: Adenocarcinoma; Amino Acid Motifs; Amino Acid Substitution; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Point Mutation; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Recombinant Fusion Proteins; Selective Estrogen Receptor Modulators; Tamoxifen; Transcription Factor AP-1; Transfection | 2010 |
Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fluorescence; Fulvestrant; Genome, Human; Humans; Lung Neoplasms; Male; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Mutant Proteins; Phosphoserine; Protein Transport; Sex Characteristics; Signal Transduction; Subcellular Fractions; Tamoxifen | 2010 |
The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cholesterol; Clinical Trials as Topic; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Inflammation; Lipid Metabolism; Liver; Menopause; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators | 2009 |
Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxins; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Epothilones; Estradiol; Female; Fulvestrant; Humans; Intracellular Signaling Peptides and Proteins; Nanoparticles; Neoplasm Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Salvage Therapy; TOR Serine-Threonine Kinases | 2009 |
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Disease-Free Survival; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Insulin; Insulin-Like Growth Factor I; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Protein-Tyrosine Kinases; Pyrazines; Random Allocation; Receptor, IGF Type 1; Receptor, Insulin; Receptors, Estrogen; RNA Interference; Signal Transduction; Tamoxifen; Xenograft Model Antitumor Assays | 2011 |
Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Estradiol; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Receptors, Estrogen; Signal Transduction; Up-Regulation | 2012 |
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Norpregnenes; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Receptors, Steroid; STAT1 Transcription Factor | 2012 |
IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Caspase 7; Cell Line, Tumor; DNA, Complementary; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Library; Heat-Shock Proteins; Humans; Insulin-Like Growth Factor Binding Protein 3; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Protein Interaction Mapping; Tamoxifen; Two-Hybrid System Techniques | 2012 |
Estrogenic effects of fusarielins in human breast cancer cell lines.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epoxy Compounds; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Fulvestrant; Fungal Proteins; Fusarium; Humans; Indicators and Reagents; MCF-7 Cells; Oxazines; Plant Extracts; Receptors, Estrogen; Xanthenes | 2012 |
In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichloroethene on 17beta-estradiol-induced gene expression in several bioassay systems.
Topics: Adenocarcinoma; Animals; Biphenyl Compounds; Breast Neoplasms; Carps; Cell Line; Cell Survival; Cytochrome P-450 CYP1A1; Dichlorodiphenyl Dichloroethylene; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Hepatocytes; Humans; Luciferases; Male; Polychlorinated Biphenyls; Rats; Tamoxifen; Vitellogenins | 2002 |
Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Cycle Proteins; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; DNA-Binding Proteins; E2F Transcription Factors; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; G1 Phase; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proto-Oncogene Proteins; Receptors, Estrogen; Recombinant Fusion Proteins; S Phase; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured | 2002 |
Cyr61 promotes breast tumorigenesis and cancer progression.
Topics: Adenocarcinoma; Breast Neoplasms; Collagen; Cysteine-Rich Protein 61; Disease Progression; Down-Regulation; Drug Combinations; Drug Resistance, Neoplasm; Endothelial Growth Factors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Laminin; Lymphokines; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proteoglycans; Receptors, Estrogen; Recombinant Fusion Proteins; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Protein Synthesis Inhibitors; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Transfection; Vascular Endothelial Growth Factor A | 2003 |
The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Northern; Cells, Cultured; Cloning, Molecular; Down-Regulation; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Receptors, Progesterone; RNA, Messenger; Selective Estrogen Receptor Modulators; Sheep; Stromal Cells; Time Factors; Transforming Growth Factor alpha; Tumor Cells, Cultured; Up-Regulation | 2003 |
Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Breast; Breast Neoplasms; Caspase 3; Caspases; Cells, Cultured; Enzyme Induction; Epithelial Cells; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, p53; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Neoplasm; Stimulation, Chemical; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Estrogenic and antiestrogenic regulation of MMP-2 and MMP-13 mRNA in RUCA-I endometrial tumor cells in vitro and in vivo.
Topics: Adenocarcinoma; Collagenases; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Endometrial Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Flavonoids; Fulvestrant; Humans; Indoles; Isoquinolines; Ligands; MAP Kinase Signaling System; Phosphoprotein Phosphatases; Phosphorylation; Point Mutation; Sulfonamides; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured | 2004 |
Direct action of estradiol on gonadotropin-releasing hormone-1 neuronal activity via a transcription-dependent mechanism.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Calcium; Calcium Signaling; Estradiol; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fluorescent Dyes; Fulvestrant; Gonadotropin-Releasing Hormone; Humans; Mice; Nasal Mucosa; Neurons; Organ Culture Techniques; Organic Chemicals; Secretory Rate; Sodium Channel Blockers; Tetrodotoxin; Transcription, Genetic | 2004 |
[Effects of ICI182780 (Faslodex) on proliferation and apoptosis induced by 17beta-estradiol in endometrial carcinoma cells].
Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flow Cytometry; Fulvestrant; Humans | 2006 |
Induction of acquired resistance to antiestrogen by reversible mitochondrial DNA depletion in breast cancer cell line.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Blotting, Southern; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Progression; DNA, Mitochondrial; DNA, Neoplasm; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Ethidium; Female; Flow Cytometry; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen | 2008 |
MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; DNA Damage; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Estrogens; Etoposide; Fulvestrant; Humans; Mechlorethamine; Neoplasms, Hormone-Dependent; Tumor Cells, Cultured | 1995 |
Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Base Sequence; Blotting, Northern; Cell Division; Colonic Neoplasms; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Mice; Molecular Sequence Data; Oligonucleotides, Antisense; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1994 |
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.
Topics: Adenocarcinoma; Animals; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; DNA, Neoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Hydroxytestosterones; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Protein Binding; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Benzopyrans; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasm Proteins; Piperidines; Propionates; Raloxifene Hydrochloride; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1997 |
Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.
Topics: Adenocarcinoma; Androstadienes; Breast Neoplasms; Butadienes; Chromones; Culture Media, Serum-Free; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Depression, Chemical; DNA Replication; Enzyme Activation; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Flavonoids; Fulvestrant; Humans; Isoquinolines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitosis; Morpholines; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Retinoblastoma Protein; Sulfonamides; Wortmannin | 2000 |
Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Basement Membrane; Breast Neoplasms; Cell Adhesion; Collagen; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Laminin; Microscopy, Electron, Scanning; Microvilli; Neoplasm Invasiveness; Neoplasm Metastasis; Proteoglycans; Pseudopodia; Tamoxifen; Tumor Cells, Cultured | 1999 |
Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.
Topics: Adenocarcinoma; Antigens, Polyomavirus Transforming; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; G1 Phase; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Protein Structure, Tertiary; Recombinant Fusion Proteins; Retinoblastoma Protein; Tamoxifen; Transfection; Tumor Cells, Cultured | 2000 |
Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa).
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgens; Cell Differentiation; Cell Nucleus; Diethylstilbestrol; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Flutamide; Fulvestrant; Humans; Metribolone; Progesterone; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2000 |
Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Topics: Adenocarcinoma; Antibodies; Breast Neoplasms; Cell Division; Cysteine-Rich Protein 61; Dactinomycin; DNA, Neoplasm; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Immediate-Early Proteins; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Expression and regulation of Cyr61 in human breast cancer cell lines.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Breast Neoplasms; Calcitriol; Cysteine-Rich Protein 61; Drug Resistance; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Immediate-Early; Growth Substances; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phenotype; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Selective Estrogen Receptor Modulators; Tamoxifen; Tetradecanoylphorbol Acetate; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured | 2002 |